Identifcation of Key Genes and Pathways Related to Nonalcoholic Fatty Liver Disease based on GEO Databases

Zheng Liang; July Liang Chen

doi:10.54691/3716ej02

Authors

Zheng Liang
July Liang Chen

DOI:

https://doi.org/10.54691/3716ej02

Keywords:

NAFLD; GEO; KEGG.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) represents a growing global health crisis and is closely associated with increases in obesity and type 2 diabetes. Despite its ubiquity, its underlying biochemical mechanisms and effective therapeutic strategies remain poorly defined, hampering the development of targeted interventions. Methods: Candidate genes were obtained from the GEO database, and Kyoto Encyclopedia of Genes and Genomes enrichment analysis and gene set enrichment analysis were used to identify pathways involved in NAFLD-related pathways. The top genes with higher degree in the protein-protein interaction network were crossed with the top genes enriched in key pathways, and then the correlation analysis between key genes and chemotherapy response was performed. Result: fatty acid metabolic process, lipid transport, response to stilbenoid, etc. are key pathways related to NAFLD. Btc, Apoa4, Gdf6 AND Ifi2712b were enriched in key pathways of NAFLD. Conclusion: Fatty acid metabolic process, lipid transport, pathway are key pathways related to NAFLD.

Downloads

Download data is not yet available.

References

C-P Day, James O-F. Steatohepatitis: a tale of two "hits"?[J]. Gastroenterology, 1998, 114(4): 842-845.

R Loomba, Friedman S-L, Shulman G-I. Mechanisms and disease consequences of nonalcoholic fatty liver disease[J]. Cell, 2021, 184(10): 2537-2564.

H Tilg, Moschen A-R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis[J]. Hepatology, 2010, 52(5): 1836-1846.

M Mota, Banini B-A, Cazanave S-C, et al. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease[J]. Metabolism, 2016, 65(8): 1049-1061.

Q Ren, Sun Q, Fu J. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease[J]. Autophagy, 2024, 20(2): 221-241.

U-S Udoh, Rajan P-K, Nakafuku Y, et al. Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma[J]. Int J Mol Sci, 2022, 23(14).

Y Filali-Mouncef, Hunter C, Roccio F, et al. The menage a trois of autophagy, lipid droplets and liver disease[J]. Autophagy, 2022, 18(1): 50-72.

N Martinez-Lopez, Singh R. Autophagy and Lipid Droplets in the Liver[J]. Annu Rev Nutr, 2015, 35215-237.

H-S Park, Song J-W, Park J-H, et al. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation[J]. Autophagy, 2021, 17(9): 2549-2564.

S Byun, Seok S, Kim Y-C, et al. Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase[J]. Nat Commun, 2020, 11(1): 807.

X Deng, Liu B, Jiang Q, et al. CREBH promotes autophagy to ameliorate NASH by regulating Coro1a[J]. Biochim Biophys Acta Mol Basis Dis, 2024, 1870(1): 166914.

E-M Trifylli, Kriebardis A-G, Koustas E, et al. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management[J]. Int J Mol Sci, 2022, 23(20).

H Qian, Chao X, Williams J, et al. Autophagy in liver diseases: A review[J]. Mol Aspects Med, 2021, 82100973.

S Zhao, Guo Y, Yin X. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease[J]. Front Biosci (Landmark Ed), 2023, 28(12): 332.

Z Cheng, Chu H, Zhu Q, et al. Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications[J]. Front Nutr, 2023, 101090338.

L Zhu, Luo S, Zhu Y, et al. The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge[J]. J Inflamm Res, 2023, 16381-389.

G Guo, Yang W, Sun C, et al. Dissecting the potential role of ferroptosis in liver diseases: an updated review[J]. Free Radic Res, 2023, 57(4): 282-293.

Y Gong, Liu Z, Zhang Y, et al. AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus[J]. Cell Death Discov, 2023, 9(1): 178.

X Zhou, Fu Y, Liu W, et al. Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges[J]. Front Mol Biosci, 2022, 9928321.

S Wei, Qiu T, Wang N, et al. Ferroptosis mediated by the interaction between Mfn2 and IREalpha promotes arsenic-induced nonalcoholic steatohepatitis[J]. Environ Res, 2020, 188109824.

W Xu, Hu Z, Zhang J, et al. Cross-talk between autophagy and ferroptosis contributes to the liver injury induced by fluoride via the mtROS-dependent pathway[J]. Ecotoxicol Environ Saf, 2023, 250114490.

B Zhou, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death[J]. Semin Cancer Biol, 2020, 6689-100.

Z Zhang, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells[J]. Autophagy, 2020, 16(8): 1482-1505.

J Liu, Huang C, Liu J, et al. Nrf2 and its dependent autophagy activation cooperatively counteract ferroptosis to alleviate acute liver injury[J]. Pharmacol Res, 2023, 187106563.